In agreement, two studies that focused on a pediatric population suffering from NLUTD due to myelodysplasia demonstrated good diagnostic performance of urinary TIMP-2 for adverse urodynamic parameters, suggesting that invasive urodynamic studies in patients with low urinary TIMP-2 levels could be avoided during follow-up. The gene discussed is TIMP2; the disease is Myelodysplasia.